- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Danish Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
3
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Zealand Pharma
Market Cap: DKK 32.5b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 465.90
7D
2.7%
1Y
-23.7%
Gubra
Market Cap: DKK 7.4b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 461.00
7D
18.3%
1Y
41.4%
BioPorto
Market Cap: DKK 639.2m
An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.
BIOPOR
DKK 1.37
7D
-2.6%
1Y
-17.7%